Skip to search formSkip to main contentSkip to account menu

Euphylong

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
It has been recognized recently that theophylline possesses anti-inflammatory effects that could be of clinical interest in… 
1994
1994
In a multiple-dose crossover study in 18 healthy male volunteers the steady-state pharmacokinetics of Euphylong, which has been… 
1991
1991
24 patients with COPD and delta FEV1 greater than 15% were included in a double-blind crossover study. 7 dropouts due to… 
Review
1988
Review
1988
This contribution attempts to relate the in-vitro drug release properties of theophylline from Euphylong pellets to serum… 
1988
1988
Euphylong is a sustained-release product consisting of encapsulated pellets covered with a porous membrane. Since the mechanism… 
1988
1988
Euphylong is a new anhydrous theophylline sustained-release pellet formulation developed for once-daily administration in the… 
1988
1988
Although bioequivalence between products has gained considerable importance over the last few years, the concept has not yet been… 
1988
1988
The in-vitro release method used within the scope of the galenical development of Euphylong pellets and subsequently employed on… 
1987
1987
Three separate single-dose, randomized, cross-over studies in normal, healthy volunteers were performed to investigate the… 
1986
1986
In a randomized, multiple-dose, cross-over study, serum theophylline concentrations (STC) were compared in 12 healthy volunteers…